UC HEALTH LINE: Conference Addresses Addiction Science and Treatment
CINCINNATIRegistration is now open for a conference aimed at making new substance abuse treatments available to those who need them.
Blending Addiction Science and Treatment: The Impact of Evidence-Based Practices on Individuals, Families and Communities, set for June 23, 2008, at Cincinnatis Duke Energy Center, is sponsored by the National Institute on Drug Abuse (NIDA) and is being hosted by the University of Cincinnati in conjunction with the University of Pittsburgh.
There is often a gap between addiction research and treatment, says Eugene Somoza, MD, PhD, UC adjunct professor of psychiatry and director of the Cincinnati Addiction Research Center. Its important that researchers and clinicians communicate with each other about new treatments so that these treatments can be made available to patients who need them.
Practitioners, health care providers, criminal justice professionals, researchers and policymakers are invited to attend to learn more about new advances in drug abuse treatment.
The conference will feature a variety of session topics including, but not limited to:
addiction and the brain
helping substance abusers stop smoking
managing substance abuse in primary care settings
pain management for substance abusing clients
motivational incentives and interventions
Early-bird registration, which costs $79, ends April 15. After April 15, registration is $99. Student registration is $49. The final registration deadline is May 21. For detailed program information or to register, visit www.nidablendingconference.info.
A 1992 study commissioned by NIDA and the National Institute on Alcohol Abuse and Alcoholism estimated the total economic cost of alcohol and drug abuse to be $245.7 billion. More than $97 billion of that was credited to drug abuse.
More information on addiction and substance abuse is available at www.netwellness.org, a collaborative health-information Web site run by UC, Case Western Reserve University and Ohio State University and staffed by Ohio physicians, nurses and allied health professionals.
Tags
Related Stories
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.
At least two weather patterns increase headaches, UC study suggests
June 4, 2026
University of Cincinnati physicians and collaborators identified two specific weather patterns that increase headache and migraine risk and found the preventive medication fremanezumab (Ajovy) can reduce weather‑associated headaches. The findings will be presented at the American Headache Society Annual Scientific Meeting in Orlando.
UC researcher secures $3.3M grant to study microplastics’ impact on heart
June 2, 2026
The National Institute of Environmental Health Sciences awarded a $3.3M grant to University of Cincinnati researcher Hong‑Sheng Wang, PhD, to study how microplastics and nanoplastics affect cardiovascular health.